Atlas FDA

Floseal Hemostatic Matrix (FLOSEAL)

FDA premarket approval P990009/S068 · decided 2021-12-10

Approval details

PMA number
P990009
Supplement
S068
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Floseal Hemostatic Matrix (FLOSEAL)
Generic name
Absorbable collagen hemostatic agent with thrombin
Applicant
Baxter Healthcare Corp
Date received
2021-11-23
Decision date
2021-12-10
Days to decision
17 days
Decision code
OK30
Product code
PMX
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Round Lake, IL
Statement
Addition of an alternate bottom web film for the non-contacting packaging of the Gelatin Syringe and Thrombin pouches in the 5mL and 10 mL Floseal Hemostatic Matrix device.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
PrisMax System Version 2 (K190910)Baxter Healthcare Corp2019-07-25
PrisMax Control Unit (K163530)Baxter Healthcare Corp2017-05-03
ULTRAFUSE (K130531)Baxter Healthcare Corp2014-04-08
NEUTRAL LUER ACTIVATED DEVICE (ONE-LINK NEEDLE-FREE IV CONNECTOR) AND EXTENSION SETS (K132734)Baxter Healthcare Corp2013-10-08
LARGE BORE STOPCOCK WITH ROTATING MALE LUER LOCK/LARGE BORE STOPCOCK WITH EXTENSION SET, GANG LARGE BORE STOPCOCK MANIFO (K130245)Baxter Healthcare Corp2013-03-01
INTERLINK SYSTEM BURETROL SOLUTION SETS, INTERLINK SYSTEM BURETROL SOLUTION SETS, CONTINUED, CLEARLINK SYSTEM BURETROL S (K123874)Baxter Healthcare Corp2013-01-10
INTERLINK SYSTEM LEVER LOCK CANNULA WITH CHECK VALVE, SECONDARY MEDICATION SETS, SOLUTION SETS, CONTINU-FLO SOLUTION SET (K123868)Baxter Healthcare Corp2013-01-08
FLOWEASE [SUBCUTANEOUS] INFUSION SET (K121092)Baxter Healthcare Corp2012-06-29